FDA Grants Fast Track Designation to Investigational Narcolepsy Treatment
The oral orexin 2 receptor agonist currently in phase 1b development for patients with narcolepsy.
Latest Sleep News
Editor's Picks
FDA Clears AI Software for Subtype-Specific Sleep Apnea Classification
The latest version of the SOMNUM software analyzes polysomnography data to automatically detect and differentiate obstructive, central, and mixed sleep apnea.
Your Go-To Resource for the Sleep Medicine Field
Stay informed with the latest sleep research, clinical guidelines, product innovations, and industry news — all in one curated update.Comparison Guides
Comparison Guides
Expiratory Positive Airway Pressure (EPAP) Comparison Guide
This guide compares EPAP devices on specifications including sizes, materials, warranty, payor coverage, cleaning instructions, and supporting studies.
Continuing Education
Continuing Education
Holistic & Patient-Centered Sleep Care: Earn Continuing Education
This CSTE quiz covers biopsychosocial approaches to sleep health, innovative uses of home sleep testing for therapy monitoring, and updated perspectives on restless legs syndrome.
Holistic Perspectives
Preclinical Research Highlights mGlu7 Modulation in Sleep Regulation
A newly published study shows that ADX71743, a selective mGlu7 inhibitor, significantly modulates sleep-wake regulation and stress-related neurochemistry in animal models.
Diagnostic Tools & Techniques
How to Improve Pediatric PSG Tolerance
Preparation at home, child-friendly environments, and experienced techs can improve the in-lab polysomnography experience for the youngest patients, as well as those with sensitivities or anxiety.
Treatment Modalities
The Business of Sleep Medicine
FDA Issues Warning Letter to Happiest Baby Over Unapproved SNOO Sleep Sacks, Hospital Bundle
The agency cited the manufacturer for distributing new sleep sack sizes and a clinical bassinet bundle without required clearance, alongside quality system and reporting violations.
